Lung Cancer Alliance

Last updated

Lung Cancer Alliance (LCA) was a U.S. national nonprofit organization, headquartered in Washington, D.C. Its stated purpose was to promote lung cancer awareness, reduce lung cancer mortality and end the stigma associated with lung cancer.

Contents

In 2019, LCA merged with the Bonnie J. Addario Lung Cancer Foundation to form the GO2 Foundation for Lung Cancer. [1]

History

Lung Cancer Alliance was founded in 1995 with to meet the needs of lung cancer patients and those at risk by improving outcomes, eliminating stigma and securing public health research funding.

In 2010 Lung Cancer Alliance began its first awareness program. Since then, Lung Cancer Alliance has developed many programs focused on lung cancer awareness: "Give a Scan", "National Shine a Light on Lung Cancer", and "Team Lung Love", have helped create awareness in the United States and internationally.

In February 2012, Lung Cancer Alliance took on its first major initiative, creating a national framework for lung cancer screening. In June 2012, it launched its national "No One Deserves To Die" campaign to help raise awareness and change the stigma associated with lung cancer. By the end of the campaign, more than 281 million impressions were made and market research proved a shift in sentiment around lung cancer.

Chapters

Lung Cancer Alliance has local chapters in four states and communities. They have support groups in thirty-five states. [2]

Initiatives

National Framework for Lung Cancer Screening Excellence

In February 2012, LCA announced the launch of its National Framework for Lung Cancer Screening Excellence, which included a bill of rights for those most at risk of developing lung cancer and guiding principles for lung cancer screening sites.

Lung Cancer Alliance's National Framework states that the public has a right to know if they are at risk for lung cancer, advocates for the increased use of low dose CT screenings to detect lung cancer in its early stages and offers endorsements of medical facilities that are deemed by the organization to be Centers of Excellence.

Lung Cancer Mortality Reduction Act

In 2011, Lung Cancer Alliance supported the Lung Cancer Mortality Reduction Act, which authorized government research agencies with the Department of Health and Human Services, Department of Defense and Department of Veterans Affairs to develop a plan of action to coordinate prevention, early detection and treatment research for lung cancer. The bill aimed to reduce the mortality rate of lung cancer by 50 percent by 2020. On April 6, 2011, the bill died and was referred to Committee.

Proposition 29

In June 2012, Lung Cancer Alliance's California Chapter endorsed Proposition 29, a ballot initiative to increase tobacco tax by one dollar to fund cancer research and tobacco prevention programs. It was closely defeated by California voters at the state-wide election.

Recalcitrant Cancer Research Act

On January 2, 2013, President Barack Obama signed the Recalcitrant Cancer Research Act of 2012 (H.R. 733) into law. This bill, which was included in the National Defense Authorization Act of 2013, requires the National Cancer Institute (NCI) to develop scientific frameworks for addressing cancers with survival rates of less than 50 percent. Within this act, lung cancer and pancreatic cancer were given priority status. The NCI framework must be submitted to the United States Congress within 18 months.

Related Research Articles

Lung cancer Cancer in the lung

Lung cancer, also known as lung carcinoma, since about 98–99% of all lung cancers are carcinomas, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Lung carcinomas derive from transformed, malignant cells that originate as epithelial cells, or from tissues composed of epithelial cells. Other lung cancers, such as the rare sarcomas of the lung, are generated by the malignant transformation of connective tissues, which arise from mesenchymal cells. Lymphomas and melanomas can also rarely result in lung cancer.

Cancer Group of diseases involving abnormal cell growth and spread

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. While these symptoms may indicate cancer, they can also have other causes. Over 100 types of cancers affect humans.

Preventive healthcare Prevent and minimize the occurrence of diseases

Preventive healthcare, or prophylaxis, consists of measures taken for disease prevention. Disease and disability are affected by environmental factors, genetic predisposition, disease agents, and lifestyle choices, and are dynamic processes which begin before individuals realize they are affected. Disease prevention relies on anticipatory actions that can be categorized as primal, primary, secondary, and tertiary prevention.

British Lung Foundation

The British Lung Foundation (BLF) is a British charity that promotes lung health and supports those affected by lung disease.

Lung cancer screening

Lung cancer screening refers to cancer screening strategies used to identify early lung cancers before they cause symptoms, at a point where they are more likely to be curable. Lung cancer screening is critically important because of the incidence and prevalence of lung cancer. More than 235,000 new cases of lung cancer are expected in the United States in 2021 with approximately 130,000 deaths expected in 2021. In addition, at the time of diagnosis, 57% of lung cancers are discovered in advanced stages, meaning they are more widespread or aggressive cancers. Because there is a substantially higher probability of long-term survival following treatment of localized (60%) versus advanced stage (6%) lung cancer, lung cancer screening aims to diagnose the disease in the localized stage.

American Cancer Society Cancer Action Network

The American Cancer Society Cancer Action Network is a nonprofit, nonpartisan advocacy affiliate of the American Cancer Society. It was founded in September 2001 to directly lobby the goals of the American Cancer Society, which is subject to restrictions on advocacy activities because of its tax classification. ACS CAN works to make cancer a national priority. Specifically, it advocates for better access to care, cancer prevention and early detection programs, cancer research funding, regulation of tobacco by the U.S. Food and Drug Administration, better quality of life for cancer patients, and attempts to raise awareness of and reduce cancer disparities. Members include cancer survivors, caregivers, patients, volunteers, and students, including Colleges Against Cancer.

The "war on cancer" is the effort to find a cure for cancer by increased research to improve the understanding of cancer biology and the development of more effective cancer treatments, such as targeted drug therapies. The aim of such efforts is to eradicate cancer as a major cause of death. The signing of the National Cancer Act of 1971 by United States president Richard Nixon is generally viewed as the beginning of this effort, though it was not described as a "war" in the legislation itself.

Chronic, non-communicable diseases account for an estimated 80% of total deaths and 70% of disability-adjusted life years (DALYs) lost in China. Cardiovascular diseases, chronic respiratory disease, and cancer are the leading causes of both death and of the burden of disease, and exposure to risk factors is high: more than 300 million men smoke cigarettes and 160 million adults are hypertensive, most of whom are not being treated. An obesity epidemic is imminent, with more than 20% of children aged 7–17 years in big cities now overweight or obese. Rates of death from chronic disease in middle-aged people are higher in China than in some high-income countries.

Epidemiology of cancer The study of factors in cancer causes and treatments

The epidemiology of cancer is the study of the factors affecting cancer, as a way to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments.

Tobacco control

Tobacco control is a field of international public health science, policy and practice dedicated to addressing tobacco use and thereby reducing the morbidity and mortality it causes. Since most cigarettes and cigars and hookahs contain/use tobacco, tobacco control also impacts these. E-cigarettes do not contain tobacco itself, but (often) do contain nicotine. Tobacco control is a priority area for the World Health Organization (WHO), through the Framework Convention on Tobacco Control. References to a tobacco control movement may have either positive or negative connotations.

Women and smoking

Cigarette smoking has serious health effects. In the "General health effects" and the "Unique gender differences and health effects for women" sections, this article gives specific statistics on the health effects on women and in general.

The Global Smokefree Partnership is a multipartner initiative formed to promote effective smokefree air policies worldwide. The Partnership works by helping practitioners and advocates of smokefree policies.

Cancer survival rates vary by the type of cancer, stage at diagnosis, treatment given and many other factors, including country. In general survival rates are improving, although more so for some cancers than others. Survival rate can be measured in several ways, median life expectancy having advantages over others in terms of meaning for people involved, rather than as an epidemiological measure.

Lebanon is a small middle-income country on the Eastern Mediterranean shore with a population of around 4 million Lebanese citizens, 1.2 million Syrian refugees, and half a million Palestinian refugees. It is at the third stage of its demographic transition characterized by a decline in both fertility and mortality rates. Moreover, Lebanon, like many countries in the Middle East is experiencing an epidemiological transition with an increasingly ageing population suffering from chronic and non-communicable diseases. Mortality related to non-communicable diseases is 404.4 deaths per 100,000 individuals, with an estimate of 45% due to cardiovascular diseases, making them the leading cause of death in Lebanon. Lebanon has health indices that are close to those of more developed countries, with a reported life expectancy at birth of 80.1 years and an under-five mortality rate of 9.5 per 1,000 live births in 2016. Since the end of the 15-year Lebanese Civil War in 1990, Lebanon’s health indicators have significantly improved.

The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is a cancer treatment, research and education institution with six locations in the St. Louis area. Siteman is the only cancer center in Missouri and within 240 miles of St. Louis to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). Siteman is also the only area member of the National Comprehensive Cancer Network, a nonprofit alliance of 31 cancer centers dedicated to improving the quality and effectiveness of cancer care.

The National Lung Screening Trial was a United States-based clinical trial which recruited research participants between 2002 and 2004. It was sponsored by the National Cancer Institute and conducted by the American College of Radiology Imaging Network and the Lung Screening Study Group. The major objective of the trial was to compare the efficacy of low-dose helical computed tomography and standard chest X-ray as methods of lung cancer screening. The primary study ended in 2010, and the initial findings were published in November 2010, with the main results published in 2011 in the New England Journal of Medicine.

Cancer prevention is the practice of taking active measures to decrease the incidence of cancer and mortality. The practice of prevention is dependent upon both individual efforts to improve lifestyle and seek preventive screening, and socioeconomic or public policy related to cancer prevention. Globalized cancer prevention is regarded as a critical objective due to its applicability to large populations, reducing long term effects of cancer by promoting proactive health practices and behaviors, and its perceived cost-effectiveness and viability for all socioeconomic classes.

Markey Cancer Center Hospital in Kentucky, United States

The University of Kentucky (UK) Markey Cancer Center is an academic, clinical and research center located in Lexington, Kentucky. It was established in 1985, and has grown to 28 departments across eight colleges. Markey has four clinic facilities located in three buildings, with dedicated research spaces in the Dorothy Enslow Combs Cancer Research Facility and Healthy Kentucky Research Building.

Seattle Cancer Care Alliance Cancer treatment and research center in Seattle, U.S.

Seattle Cancer Care Alliance (SCCA) is a cancer treatment and research center in Seattle, Washington. Established in 1998, this nonprofit provides clinical oncology care for patients treated at its three partner organizations: Fred Hutchinson Cancer Research Center, Seattle Children's and UW Medicine. Together, these four institutions form the Fred Hutch/University of Washington Cancer Consortium.

Suicide awareness

Suicide awareness is a proactive effort to raise awareness around suicidal behaviors. It is focused on reducing social stigmas and ambiguity, by bringing attention to suicide statistically and sociologically, and encouraging positive dialogue and engagement as a means to prevent suicide. Suicide awareness is linked to suicide prevention as both address suicide education and the dissemination of information to ultimately decrease the rate of suicide. Awareness is a first stage that can ease the need for prevention. Awareness signifies a fundamental consciousness of the threat, while prevention focuses on stopping the act. Suicide awareness is not a medical engagement, but a combination of medical, social, emotional and financial counseling. Suicide awareness in adolescents focuses on the age group between 10–24 years, beginning with the onset of puberty.

References

  1. Johnson, Bethany. "Our History". GO2 Foundation for Lung Cancer. Retrieved 2021-12-05.
  2. "National Lung Cancer Support Group Network - Lung Cancer Alliance". www.lungcanceralliance.org. Retrieved 2017-04-08.